CA2011587A1 - Compose induisant la secretion d'un facteur de croissance des nerfs - Google Patents

Compose induisant la secretion d'un facteur de croissance des nerfs

Info

Publication number
CA2011587A1
CA2011587A1 CA2011587A CA2011587A CA2011587A1 CA 2011587 A1 CA2011587 A1 CA 2011587A1 CA 2011587 A CA2011587 A CA 2011587A CA 2011587 A CA2011587 A CA 2011587A CA 2011587 A1 CA2011587 A1 CA 2011587A1
Authority
CA
Canada
Prior art keywords
group
growth factor
nerve growth
factor secretion
secretion inducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2011587A
Other languages
English (en)
Other versions
CA2011587C (fr
Inventor
Giichi Goto
Kyozo Hayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of CA2011587A1 publication Critical patent/CA2011587A1/fr
Application granted granted Critical
Publication of CA2011587C publication Critical patent/CA2011587C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002011587A 1989-08-24 1990-03-06 Compose induisant la secretion d'un facteur de croissance des nerfs Expired - Fee Related CA2011587C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP218255-1989 1989-08-24
JP1218255A JPH08768B2 (ja) 1989-08-24 1989-08-24 神経成長因子分泌誘導剤

Publications (2)

Publication Number Publication Date
CA2011587A1 true CA2011587A1 (fr) 1991-02-24
CA2011587C CA2011587C (fr) 1999-11-23

Family

ID=16717022

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002011587A Expired - Fee Related CA2011587C (fr) 1989-08-24 1990-03-06 Compose induisant la secretion d'un facteur de croissance des nerfs

Country Status (3)

Country Link
US (1) US5059627A (fr)
JP (1) JPH08768B2 (fr)
CA (1) CA2011587C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19504003A1 (de) * 1995-02-08 1996-08-14 Martin Dr Kohlmeier Verwendungen eines Vitamins der K-Gruppe

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5416242A (en) * 1992-09-25 1995-05-16 Nippon Hypox Laboratories Incorporated Hydroquinone derivative
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases
ES2136167T3 (es) * 1993-06-18 1999-11-16 Takeda Chemical Industries Ltd Composiciones de idebenona para tratar la enfermedad de alzheimer.
DE19549262C2 (de) * 1995-02-08 1997-10-09 Martin Dr Kohlmeier Präparat zur Abschätzung des Entstehungsrisikos eines beschleunigten Verlustes kognitiver Fähigkeiten
EP0846109B1 (fr) * 1995-08-21 2002-07-24 Takeda Chemical Industries, Ltd. Compose de quinone, sa production et son utilisation
EP0788793A1 (fr) * 1996-02-01 1997-08-13 Takeda Chemical Industries, Ltd. Idébenone pour le traitement de la démence
DE69712888D1 (de) 1996-07-11 2002-07-04 Takeda Chemical Industries Ltd ZUSAMMENSTELLUNGEN DIE beta-AMYLOID PROTEIN BEDINGTE ZYTOTOXIZITÄT VERHINDERN
US5962535A (en) * 1997-01-17 1999-10-05 Takeda Chemical Industries, Ltd. Composition for alzheimer's disease
HUP0002482A3 (en) 1997-02-03 2003-01-28 Takeda Chemical Industries Ltd Bicyclic quinone compounds, their production pharmaceutical compositions thereof and intermediates
AU8562998A (en) * 1997-08-12 1999-03-01 Takeda Chemical Industries Ltd. Idebenone-containing preparation for percutaneous administration
DE19932197A1 (de) 1999-07-09 2001-01-18 Neudecker Birgit Topisch anzuwendendes Mittel mit schützender und regenerativer Wirkung
AU2001228825A1 (en) * 2000-01-27 2001-08-07 Takara Bio Inc. Remedies
EP1293200A4 (fr) * 2000-02-08 2004-10-13 Hisamitsu Pharmaceutical Co Potentialisateurs du facteur de croissance neuronal
TWI329513B (en) * 2001-10-12 2010-09-01 Kaneka Corp Use of reduced coenzyme q for lessening oxidative stress
JP2003226639A (ja) * 2002-01-31 2003-08-12 Hisamitsu Pharmaceut Co Inc 神経成長因子活性増強剤としてのビタミンｋ類を含む医薬組成物およびその使用
FR2860233B1 (fr) * 2003-09-26 2007-10-19 Univ Pasteur Composes promoteurs de la differenciation des precurseurs d'oligodendrocytes et modulateurs de l'activation microgliale, compositions et utilisations.
US20050152857A1 (en) * 2004-01-08 2005-07-14 Pcr Technology Holdings, Lc Method and preparation for reducing sunburn cell formation in skin
US20050175559A1 (en) * 2004-02-10 2005-08-11 Pcr Technology Holdings, Lc Method and preparation for reducing skin hyperpigmentation
US20050197407A1 (en) * 2004-02-13 2005-09-08 Pcr Technology Holdings, Lc Method and preparation for reducing irritation and/or inflammatory reaction in human skin
JP5150807B2 (ja) * 2005-02-28 2013-02-27 株式会社明治 ハイドロキノン長鎖誘導体及び／又はフェノキシ長鎖誘導体及びこれらを含有する医薬
ES2714900T3 (es) 2005-06-01 2019-05-30 Bioelectron Tech Corp Productos terapéuticos redox activos para el tratamiento de enfermedades mitocondriales y otras afecciones y modulación de biomarcadores energéticos
ES2823728T3 (es) * 2005-09-15 2021-05-10 Ptc Therapeutics Inc Variantes de cola de agentes terapéuticos con actividad redox para el tratamiento de enfermedades mitocondriales y otras afecciones y la modulación de biomarcadores de energía
AR053665A1 (es) * 2006-01-23 2007-05-16 Creactivar S A Uso de la mimosina o un derivado de la misma, en el tratamiento de las manifestaciones cutaneas de la psoriasis y de los desordenes cutaneos relacionados con esta y una composicion cosmetica o farmaceutica que la comprende
WO2007100652A2 (fr) 2006-02-22 2007-09-07 Edison Pharmaceuticals, Inc. Variants à chaînes latérales d'agents thérapeutiques ayant une activité oxydoréductrice pour le traitement de maladies mitochondriales et d'autres conditions et pour la modulation de biomarqueurs énergétiques
JP4845038B2 (ja) * 2007-03-01 2011-12-28 敏雄 鈴木 鋼材コイル転倒防止具及び転倒防止方法
LT3827815T (lt) 2008-09-10 2023-10-10 Ptc Therapeutics, Inc. Psichologinių raidos sutrikimų gydymas oksidacijos redukcijos atžvilgiu aktyviais vaistais
CA2908929C (fr) 2012-07-12 2021-01-26 Concert Pharmaceuticals, Inc. Idebenone deuteree
CA3008849A1 (fr) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Derives fluoroalkyle, fluoroalcoxy, phenoxy, heteroaryloxy, alcoxy, et amine 1,4-benzoquinone pour le traitement de troubles du stress oxydatif
EP4257190A3 (fr) 2018-10-17 2024-01-03 PTC Therapeutics, Inc. 2,3,5-triméthyl-6-nonylcyclohexa-2,5-diène-1,4-dione pour la suppression et le traitement des alpha-synucléinopathies, des tauopathies et d'autres troubles
IL310011A (en) 2021-07-08 2024-03-01 Ptc Therapeutics Inc Pharmaceutical compositions containing 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5697223A (en) * 1979-12-30 1981-08-05 Takeda Chem Ind Ltd Tissue metabolism activator
US4393075A (en) * 1980-04-14 1983-07-12 Takeda Chemical Industries, Ltd. Quinone compounds and their use in suppressing the production of SRS-A in mammals
MX9203040A (es) * 1984-08-01 1992-07-31 Takeda Chemical Industries Ltd Derivados de quinona y composicion farmaceutica que los contiene.
IL81264A (en) * 1986-01-30 1990-11-05 Takeda Chemical Industries Ltd Quinone derivatives,their production and pharmaceutical compositions containing them
US4851431A (en) * 1986-11-26 1989-07-25 Bar Ilan University Physiologically active and nutritional composition
JPH0813741B2 (ja) * 1987-08-10 1996-02-14 協和醗酵工業株式会社 抗痴呆剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19504003A1 (de) * 1995-02-08 1996-08-14 Martin Dr Kohlmeier Verwendungen eines Vitamins der K-Gruppe

Also Published As

Publication number Publication date
US5059627A (en) 1991-10-22
CA2011587C (fr) 1999-11-23
JPH08768B2 (ja) 1996-01-10
JPH0381218A (ja) 1991-04-05

Similar Documents

Publication Publication Date Title
CA2011587A1 (fr) Compose induisant la secretion d'un facteur de croissance des nerfs
IL107551A0 (en) Novel compounds useful as sweetening agents and their method of preparation
AU8682191A (en) Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use
AU572497B2 (en) 1,2,3,4-tetrahydro-2-naphthylamines
PH31464A (en) 2-Piperidino-1-alkanol derivatives as antiischemicagents.
MY104335A (en) 4-aminophridine deravatives
CA2016860A1 (fr) Derives de 2-piperidino-1-alkanol antiischemique
CA2202032A1 (fr) Potentialisateur de l'activite du facteur de croissance nerveuse contenant un derive de 1,2-ethanediol ou un sel de celui-ci
IE810153L (en) Cyclohexenes
HUT57694A (en) Process for producing new beta-diketones and pharmaceutical compositions comprising same
DE3572814D1 (en) 1, 3-benzoxathiole derivatives, their use and their preparation
IE821441L (en) Orally effective aporphine compounds
HU905000D0 (en) Process for producing compounds suitable for treatment of gastric ulcer
AU6919398A (en) Heterocyclic compounds and their preparation and use
AU7843991A (en) Enantiomers of 2-tetrahydrofuran derivatives and their preparation
AU2148899A (en) 15-methyl-cyclopropanosteroids and method for the production thereof
CA2270026A1 (fr) Derives bicycliques substitues pour le traitement des troubles du systeme nerveux central
MY105745A (en) 2-piperidino-1-alkanol derivatives as antiischemic agents.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed